Cite

HARVARD Citation

    Guerrieri‐Gonzaga, A. et al. (n.d.). Benefit of low‐dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS. International journal of cancer. 139 (9), pp. 2127-2134. [Online]. 
  
Back to record